- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Prostatype Genomics AB (PROGEN)Prostatype Genomics AB stock price live, this page displays ST PROGEN stock exchange data. View the PROGEN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Prostatype Genomics AB real time stock price chart below.
What Is the Prostatype Genomics AB Stock Price Today?
The Prostatype Genomics AB stock price today is 8.90.
What Is the Stock Symbol for Prostatype Genomics AB?
The stock symbol for Prostatype Genomics AB is "PROGEN."
What Stock Exchange Does Prostatype Genomics AB Trade On?
Prostatype Genomics AB is listed and trades on the Stockholm stock exchange.
Is Prostatype Genomics AB a Good Stock to Buy?
Determining whether Prostatype Genomics AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PROGEN quote. (ISIN: SE0023261532)
What Is the Prostatype Genomics AB Stock Price Today?
The Prostatype Genomics AB stock price today is 8.90.
What Is the Stock Symbol for Prostatype Genomics AB?
The stock symbol for Prostatype Genomics AB is "PROGEN."
What Stock Exchange Does Prostatype Genomics AB Trade On?
Prostatype Genomics AB is listed and trades on the Stockholm stock exchange.
Is Prostatype Genomics AB a Good Stock to Buy?
Determining whether Prostatype Genomics AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PROGEN quote. (ISIN: SE0023261532)
Stockholm
Currency in SEK
8.90
+0.85(+10.56%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.40
10.00
52 wk Range
5.17
112.73
PROGEN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.4010.00
52 wk Range
5.17112.73
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockPROGEN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Prostatype Genomics AB Company Profile
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The company’s test is based on database containing prostate cancer patients, as well as provides decision support for patients and doctors when making a treatment decision. Prostatype Genomics AB (publ) was incorporated in 2007 and is based in Solna, Sweden.
Compare PROGEN to Peers and Sector
Metrics to compare | PROGEN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPROGENPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.2x | −1.8x | −0.7x | |
PEG Ratio | 0.00 | −0.02 | 0.00 | |
Price/Book | 0.6x | 2.5x | 2.6x | |
Price / LTM Sales | 1.9x | 7.0x | 3.2x | |
Upside (Analyst Target) | - | 126.4% | 43.2% | |
Fair Value Upside | Unlock | 27.5% | 6.8% | Unlock |
FAQ
What Is the Prostatype Genomics AB (PROGEN) Stock Price Today?
The Prostatype Genomics AB stock price today is 8.90.
What Stock Exchange Does Prostatype Genomics AB Trade On?
Prostatype Genomics AB is listed and trades on the Stockholm stock exchange.
What Is the Stock Symbol for Prostatype Genomics AB?
The stock symbol for Prostatype Genomics AB is "PROGEN."
What Is the Prostatype Genomics AB Market Cap?
As of today, Prostatype Genomics AB market cap is 7.98M.
What is Prostatype Genomics AB Earnings Per Share?
The Prostatype Genomics AB EPS is -109.66.
From a Technical Analysis Perspective, Is PROGEN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.